CRISPR start-up Graphite Bio launches with $45 million for targeted DNA integration

Wednesday, September 16, 2020 - 16:10 in Biology & Nature

Firm's initial focus is sickle cell disease, based on work by Stanford scientist Matthew Porteus

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net